XJPX6523
Market cap787mUSD
Jan 21, Last price
972.00JPY
1D
0.83%
1Q
-1.42%
IPO
-63.87%
Name
PHC Holdings Corp
Chart & Performance
P/E
—
P/S
0.35
EPS
—
Div Yield, %
4.01%
Shrs. gr., 5y
1.16%
Rev. gr., 5y
13.66%
Revenues
353.90b
-0.71%
Net income
-12.89b
L+300.25%
CFO
41.30b
+93.23%
Dividend
Mar 28, 20250 JPY/sh
Profile
PHC Holdings Corporation, through its subsidiaries, develops, manufactures, and sells medical devices, healthcare technology solutions, and life science products. The company offers blood glucose monitoring systems and other testing/analysis devices, as well as data linkage solutions; anatomical pathology solutions, such as instruments, microscope slides, and dyeing reagents; and equipment and services for various sample preservation and cell culture in the life sciences field. It also provides healthcare IT products in the field of medical information systems for clinics and healthcare insurance pharmacies. In addition, the company engages in clinical testing, diagnostic reagents, and drug development support businesses. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. The company was founded in 2014 and is headquartered in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | |
| Income | ||||||
Revenues | 353,900,000 -0.71% | 356,434,000 4.69% | 340,452,000 11.23% | |||
Cost of revenue | 339,403,000 | 346,921,000 | 333,998,000 | |||
Unusual Expense (Income) | ||||||
NOPBT | 14,497,000 | 9,513,000 | 6,454,000 | |||
NOPBT Margin | 4.10% | 2.67% | 1.90% | |||
Operating Taxes | (391,000) | 3,228,000 | 11,302,000 | |||
Tax Rate | 33.93% | 175.12% | ||||
NOPAT | 14,888,000 | 6,285,000 | (4,848,000) | |||
Net income | (12,892,000) 300.25% | (3,221,000) -61.93% | (8,460,000) -150.04% | |||
Dividends | (9,040,000) | (9,196,000) | ||||
Dividend yield | 5.81% | 5.15% | ||||
Proceeds from repurchase of equity | 231,000 | (5,564,000) | 20,829,000 | |||
BB yield | -0.15% | 3.12% | -9.64% | |||
| Debt | ||||||
Debt current | 36,922,000 | 30,212,000 | 27,251,000 | |||
Long-term debt | 257,091,000 | 271,555,000 | 290,603,000 | |||
Deferred revenue | 21,510,000 | 23,509,000 | ||||
Other long-term liabilities | 20,531,000 | 1,673,000 | 1,528,000 | |||
Net debt | 226,019,000 | 217,381,000 | 193,686,000 | |||
| Cash flow | ||||||
Cash from operating activities | 41,304,000 | 21,376,000 | 51,053,000 | |||
CAPEX | (14,630,000) | (11,516,000) | (11,736,000) | |||
Cash from investing activities | (21,072,000) | (17,520,000) | (12,521,000) | |||
Cash from financing activities | (39,139,000) | (40,832,000) | (7,015,000) | |||
FCF | 19,609,000 | (19,489,000) | (6,492,000) | |||
| Balance | ||||||
Cash | 51,819,000 | 63,254,000 | 97,625,000 | |||
Long term investments | 16,175,000 | 21,132,000 | 26,543,000 | |||
Excess cash | 50,299,000 | 66,564,300 | 107,145,400 | |||
Stockholders' equity | 97,935,000 | 203,854,000 | 211,482,000 | |||
Invested Capital | 394,441,000 | 385,667,700 | 358,672,600 | |||
ROIC | 3.82% | 1.69% | ||||
ROCE | 3.19% | 2.07% | 1.35% | |||
| EV | ||||||
Common stock shares outstanding | 125,813 | 124,686 | 119,528 | |||
Price | 1,236.00 -13.69% | 1,432.00 -20.80% | 1,808.00 | |||
Market cap | 155,504,868 -12.91% | 178,550,352 -17.38% | 216,106,624 | |||
EV | 381,172,868 | 504,852,352 | 529,450,624 | |||
EBITDA | 42,430,000 | 38,528,000 | 37,531,000 | |||
EV/EBITDA | 8.98 | 13.10 | 14.11 | |||
Interest | 15,464,000 | 20,231,000 | 7,520,000 | |||
Interest/NOPBT | 106.67% | 212.67% | 116.52% | |||